Form 8-K · Current report
Mettler Toledo 8-K, filed Jul 30, 2026
- Filed
- CIK
- 0001037646
- Accession no.
- 0001037646-26-000049
Summary
Mettler-Toledo International reported second-quarter 2026 sales up 4% from a year earlier, or 6% in local currency excluding a one-time tariff refund to customers, with diluted earnings per share of $11.55 versus $9.76 in the prior-year period. The company filed the results with the SEC under Item 2.02 and furnished a press release covering the three and six months ended June 30, 2026.
Key points
- Reported sales rose 4% year over year; in local currency, sales rose 6% excluding a one-time tariff refund to customers.
- Diluted earnings per share were $11.55, compared with $9.76 in the prior-year period.
- Results cover the three and six months ended June 30, 2026.
- The filing presents non-GAAP measures including Adjusted Earnings per Share, Adjusted Operating Profit, Adjusted Free Cash Flow and Local Currency Sales Growth, with reconciliations in the accompanying release.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition.” The information furnished in this Form 8-K and the Exhibit attached hereto shall not be treated as filed for purposes of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. On July 30, 2026 Mettler-Toledo International Inc. ("Mettler-Toledo") issued a press release (the Release) setting forth its financial results for the three and six months ended June 30, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.